A Comparison of Two Daily Disposable Soft Contact Lenses

Exclusion Criteria

• •1. Currently pregnant or breastfeeding (subjects who become pregnant during the study will be discontinued).
• •2. Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• •3. Any autoimmune disease or use of any medication, which may interfere with contact lens wear.
• •4. Entropoin, Ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.
• •5. Any previous, or planned ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.)
• •6. Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related inflammatory event (e.g. past peripheral ulcer or round scar), or any other ocular abnormality that may contraindicate contact lens wear.
• •7. Any ocular infection.
• •8. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• •9. Monovision, multifocal, toric, or extended wear contact lens correction.
• •10. Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
• •11. History of binocular vision abnormality or strabismus.
• •12. Any infectious disease (e.g. hepatitis, tuberculosis) or contagious immunosuppressive disease (e.g. HIV) by self-report.